ALEJANDRO LERMA: Open Payments
NPI 1679892566 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 29 payments from 13 companies in 2025. Trend: 2023 $878 · 2024 $614 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $166 |
| Dexcom, Inc. | 1 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $146 |
| Abbott Laboratories | 2 | $48 |
| ABBVIE INC. | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| CVRx, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: DEXCOM G7 GSS (161), Kerendia, FREESTYLE LIBRE 3, Rybelsus, Ozempic, GEMTESA, CREON, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
